SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-24-000467
Filing Date
2024-01-03
Accepted
2024-01-03 17:01:02
Documents
2
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1491
2 EXHIBIT 24.1 ef20017906_ex24-1.htm EX-24.1 10240
  Complete submission text file 0001140361-24-000467.txt   13442
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 155 THOMPSON DR. HOCKESSIN DE 19707
Business Address
Luther Sanjeev (Reporting) CIK: 0001933592 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 24507872